Expert Review of Anticancer Therapy
Volume 21, 2021 - Issue 12
Original Research
Cost-effectiveness of lenalidomide plus rituximab versus rituximab monotherapy in patients with previously treated follicular lymphoma: a societal view
Frederick W Thielena Section Health Technology Assessment, Erasmus School of Health Policy and Management/Institute for Medical Technology Assessment, Erasmus University, Rotterdam, The NetherlandsCorrespondence[email protected]
https://orcid.org/0000-0002-0312-5891View further author information
https://orcid.org/0000-0002-0312-5891View further author information, Marie-José Kerstenb Division of Haematology, Amsterdam University Medical Centers, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlandshttps://orcid.org/0000-0002-8904-3802View further author information
https://orcid.org/0000-0002-8904-3802View further author information, , Mels Hoogendoornd Division of Haematology, Medical Center Leeuwarden, Leeuwarden, The Netherlandshttps://orcid.org/0000-0001-8032-2592View further author information
https://orcid.org/0000-0001-8032-2592View further author information, Eduardus FM Posthumae Department of Internal Medicine, Leiden University Medical Center & Reinier de Graaf Hospital, Delft, The Netherlandshttps://orcid.org/0000-0002-0882-2346View further author information
https://orcid.org/0000-0002-0882-2346View further author information, , Carin A Uyl-de Groota Section Health Technology Assessment, Erasmus School of Health Policy and Management/Institute for Medical Technology Assessment, Erasmus University, Rotterdam, The Netherlandshttps://orcid.org/0000-0001-5808-302XView further author information
https://orcid.org/0000-0001-5808-302XView further author information & Hedwig M Blommesteina Section Health Technology Assessment, Erasmus School of Health Policy and Management/Institute for Medical Technology Assessment, Erasmus University, Rotterdam, The Netherlandshttps://orcid.org/0000-0002-5846-0531View further author information
https://orcid.org/0000-0002-5846-0531View further author information show all